Qing-Guo Zhong

Engineering immune cells with membrane-fusogenic liposomes: A new frontier in adoptive cell therapy

Adoptive cell therapy continues to encounter diverse hurdles in treating solid tumors, including poor infiltration, an immunosuppressive microenvironment, and tumor immune evasion, necessitating the endowment of effector cells with multiple functionalities. However, conventional cell-engineering techniques, including g...